Download presentation
Presentation is loading. Please wait.
Published byΦυλλίδος Ζάνος Modified over 5 years ago
1
High prevalence of severe asthma in a large random population study
Roxana Mincheva, MD, PhD, Linda Ekerljung, PhD, Apostolos Bossios, MD, PhD, Bo Lundbäck, MD, PhD, Jan Lötvall, MD, PhD Journal of Allergy and Clinical Immunology Volume 141, Issue 6, Pages e2 (June 2018) DOI: /j.jaci Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions
2
Journal of Allergy and Clinical Immunology 2018 141, 2256-2264
Journal of Allergy and Clinical Immunology , e2DOI: ( /j.jaci ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions
3
Fig 1 Flowchart showing the study design and selection of the asthmatic and control groups. Journal of Allergy and Clinical Immunology , e2DOI: ( /j.jaci ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions
4
Fig 2 Venn diagram showing the proportions of patients with active asthma who present with the individual severity signs, as well as their degree of overlap. OCS, Oral corticosteroid. Journal of Allergy and Clinical Immunology , e2DOI: ( /j.jaci ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions
5
Fig 3 Difference in mean ACT scores between the groups of patients with nonsevere asthma, patients with 1 sign of severe asthma, and patients with 2 or more signs of severe asthma. ***P < .001. Journal of Allergy and Clinical Immunology , e2DOI: ( /j.jaci ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions
6
Fig 4 Prevalence of symptoms in the patients with nonsevere asthma, patients who report 1 sign of severe asthma, and patients who report 2 or more signs of severe asthma. *P < .05 and ***P < GER, Gastroesophageal reflux; NS, not significant. Journal of Allergy and Clinical Immunology , e2DOI: ( /j.jaci ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.